June 18, 2010 (Rome, Italy) — Patients with rheumatoid arthritis and osteoarthritis treated with a selective cyclooxygenase-2 (COX-2) inhibitor for inflammation and pain were 4 to 5 times less likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback